ea0098c40 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023
Singh Grewal, MD Udhayvir
, Paschke, MD Alexander
, Dillon, MD Joseph
, Chandrasekharan, MD Chandrikha
Background: Clinicians are concerned about increased hepatotoxicity in patients who received hepatic artery bland embolizations (TAE) and subsequent Peptide Receptor Radionuclide Therapy (PRRT). The body of literature describing the safety of PRRT following prior TAE is very limited. The purpose of this study is to evaluate the degree of long-term liver toxicity in patients who received PRRT in addition to previous hepatic embolizations for liver dominant disease.<p class=...